After intrveous adminiation of brial l;oo (LPS) , polymorphomaclear neutroplul (PMNs) he sequelae of gram-negative bacterial sepsis are a major cause of morbidity and a leading cause of death in the United States (1). Gram-negative bacteria are a normal constituent of the gastrointestinal tract, and pathogenesis from these organisms can arise during systemic exposure to either whole bacteria or their constituents. Such exposure can occur through increased translocation of bacteria from the gut to the portal circulation during surgery and during a wide range of disease states, including urinary tract infections, inflammatory bowel disease, obstructive jaundice, liver disease, and cirrhosis (2) (3) (4) .
Lipopolysaccharide (LPS) is a major component of the cell wall of gram-negative bacteria and is likely responsible for many of the events that occur during sepsis (5) . Exposure to LPS can produce an array of pathophysiological changes similar to those seen during sepsis, including hypotension and multi-organ failure involving damage to the liver, lungs, kidneys, heart, and gastrointestinal tract (6) . Neutrophils (PMNs) have been implicated as playing a critical role in LPS-induced tissue damage (7, 8) . After an intravenous administration of LPS to rats, PMNs accumulate in the liver sinusoids within 1 hr, and multifocal, midzonal hepatic necrosis is prominent by 6 hr (8, 9) .
Depletion of circulating PMNs before LPS exposure protects against hepatic injury, indicating a requirement for these cells (8, 10) . Activation of PMNs is likely a necessary step in producing PMN-mediated tissue injury, and studies in vitro have demonstrated that activated PMNs can kill both endothelial cells and hepatocytes (11) (12) (13) .
Although the exact mechanisms of PMNmediated tissue injury are unknown, they probably involve production of reactive oxygen species such as the superoxide anion (°2-) and/or release of cytotoxic enzymes contained within granules (14) .
Polychlorinated biphenyls (PCBs) are industrial chemicals that have been released into the environment. In experimental animals, these compounds produce an array of toxic responses including hepatotoxicity and alterations in the immune system (15, 16) . Humans accidentally exposed to high concentrations of PCBs expressed changes in immune system parameters such as alterations in lymphocyte subpopulations and suppression of cellular immunity (17) (18) (19) . In addition, monocytes and PMNs obtained from individuals exposed to PCBs had lower percentages of cells bearing immunoglobulin and complement receptors (20) . Primates exposed to PCBs have exhibited a wide range of adverse responses including inflammatory lesions in the liver (21, 22) , and abnormal liver function tests have been reported in exposed human populations (19) .
Although immunotoxicity due to PCB exposure has been described in some detail, less is known about the interactions of these compounds with PMNs or inflammatory responses. PCBs rapidly activate PMNs in vitro to produce (Y°and to degranulate (23) . PMN activation by PCBs occurs through signal transduction pathways involving phosphoinositide hydrolysis, inositol triphosphate production, phospholipase A2 activation, and Ca2+ mobilization (24) (25) (26) (27) , which activate PMNs in vitro (26 (28) . Liver sections were fixed, embedded in paraffin, cut at 6 pm, stained with hematoxylin and eosin, and coded and evaluated without bias by a veterinary pathologist. The severity of hepatic injury was graded on a scale from 0 (no significant lesions) to 5 (severe, coalescing necrosis).
Quantification of hepatic PMN accumulation. PMNs in liver sections were visualized using an immunohistochemical technique (9) . Liver sections were fixed, embedded in paraffin, and sectioned at 6 pm. Paraffin was removed from the tissue sections with xylene before staining. PMNs within the liver tissue were stained using a rabbit anti-rat PMN immunoglobulin. This anti-PMN immunoglobulin was isolated from serum of rabbits immunized with rat PMNs as described previously (8) . After incubation with the primary antibody, the tissue sections were incubated with biotinylated goat anti-rabbit IgG, avidin-conjugated alkaline phosphatase, and Vector Red substrate to stain the PMNs within the tissue. We assessed hepatic PMN accumulation by averaging the number of PMNs counted in 20 midzonal, 400x fields throughout 3 separate lobes using light microscopy. PMNs were identified by positive staining and morphology.
Isolation ofPMNs. PMNs were isolated from the peritoneum of male SpragueDawley retired breeder rats by glycogen elicitation as described previously (29 (23, 26) . PMA (0 or 20 ng/ml) was then added for an additional 10 min at 37°C. We measured O°g enerated during this 40-min incubation period by the SOD-sensitive reduction of ferricytochrome C (30) . In a separate series of experiments, PMNs (2 x 10 cells) were incubated with LPS (10 or 100 pg/mi) or vehicle (HBSS) for 10 min, followed by exposure to Arocior 1248 (1 or 10 pg/ml) or vehicle (DMF) for an additional 30 min.
We detetected O°2 produced during this 40-min period as described above.
Assessment of PMN degranulation. Degranulation was assessed by the release of the enzyme myeloperoxidase (MPO), which is contained within azurophilic granules. PMNs were prepared in HBSS and pretreated with 5 pg/ml cytochalasin B for 10 min at room temperature to facilitate release of the granules into the incubation medium (31, 32) . PMNs (2 x 106 cells) were then exposed to either vehicle (1 pl DMF) or to 1 or 10 pg/ml Aroclor 1248 for 15 min at 37°C. We exposed PMNs to fMLP (10 nM) for 15 min at 37°C as a positive control. fMLP is a chemotactic peptide derived from gram-negative bacteria that binds to a G-protein-coupled receptor, leading to PMN activation (33, 34) . The incubation was terminated by placing the cells in an ice-water bath followed by centrifugation at 40C. The cellfree supernatant was collected, and MPO activity was measured by the H202-dependent oxidation of guaiacol (35, 36 Hepatocyte-neutrophil co-cultures. Hepatocytes were isolated according to the method of Seglen (38) as modified by Klaunig et al. (39) . Briefly, rats were anesthetized with sodium pentobarbital (50 mg/kg), and the portal vein was cannulated. The liver was perfused with approximately 150 ml of Mg2+-free, Ca2+-free HBSS followed by perfusion with 250 ml collagenase type A (0.5 mg/ml). The resulting liver digest was filtered through gauze and spun in a centrifuge at 50g for 2 (13) . The cells remaining on the plate were lysed with 1% Triton X-100, followed by sonication. Both the medium and the cell lysates were spun in a centrifuge at 600g for 10 min. The activity of ALT in the cell-free supernatant fluids was determined (using Sigma kit no. 59-UV), and the activity in the medium was expressed as a percentage of total activity (activity in the medium plus activity in the cell lysates). ALT ALT is a sensitive and specific indicator of hepatocellular damage in the rat, and in the co-culture system release of ALT from hepatocytes correlates with cell death measured by uptake of trypan blue and electron microscopy (13) . Therefore, we used ALT activity in the medium as an index of injury to the hepatocytes. To examine the mechanism by which Aroclor 1248 interacts with PMNs and kills hepatocytes, hepatocytes were cultured with cell-free conditioned medium from PMNs exposed to Aroclor 1248. PMNs in suspension (2.5 x 106 cells/ml Williams' medium E containing 0.1% gentamicin) were pretreated with cytochalasin B (5 pg/ml) for 10 min at room temperature and then exposed to either vehicle (1 1il DMF/ml cells) or
Aroclor 1248 (10 pg/mI) for 30 min at 370C. The cells were removed by centrifugation, the cell-free supernatant was collected and added to the hepatocytes (2 ml/well), and release of ALT was determined 16 hr later as described above (13 
Results
Neither exposure of PMNs to vehicle nor to 1 pg/ml Aroclor 1248 resulted in generation of°2- (Fig. 1) . However, PMNs exposed to 10 pg/ml Aroclor 1248 produced a significant amount of O°. PMA alone caused an increase in Oi-production. 6 hr after administration of LPS or saline, and liver sections were prepared from three different lobes. Severity of hepatic injury was graded on a scale of 0-5 reflecting the frequency and size of the hepatic lesions: 0 = no significant lesions; 1 = extremely mild necrosis; 2 = mild necrosis; 3 = moderate necrosis; 4 = marked necrosis; 5 = severe, coalescing necrosis. medium occurred in the absence of cytotoxicity as determined by release of LDH (data not shown). PMN degranulation in response to fMLP was included as a positive control.
Six hours after exposure to LPS alone, activities of ALT and ICDH in plasma were not significantly elevated (Fig. 2) . Administration of Aroclor 1248 (50 mg/kg) 90 min after LPS exposure resulted in significant hepatic injury, as demonstrated from increased activities of ALT and ICDH (Fig. 2) . Exposure to Aroclor 1248 in the absence of LPS had no effect on ALT or ICDH activities in plasma. Nine hours after administration of LPS alone, plasma ALT activity was increased compared to controls (Fig. 3) . Activity of ALT in plasma of rats treated with Aroclor following LPS was significantly greater than in rats receiving LPS alone. Co-administration of Aroclor 1248 with LPS resulted in lethality in 10% of the animals. Lethality was not seen in animals treated with LPS or Aroclor 1248 alone. In a separate study, administration of a smaller dose of Aroclor 1248 (10 mg/kg) did not affect LPSinduced hepatic injury as determined by activities of ALT and ICDH in plasma (data not shown). Exposure to a larger dose of Aroclor 1248 alone (100 mg/kg) did not produce hepatic injury, as evidenced from activities of ALT and ICDH in plasma (74 ± 9 and 6 ± 1 U/l, respectively; not significantly different from vehicle controls) and histologic evaluation.
There were no significant lesions in the livers of vehicle-treated rats or rats exposed to Aroclor 1248 in the absence of LPS (Table 2) . Six hours after LPS administration, livers from animals co-treated with either Aroclor 1248 or corn oil vehicle had lesions of varying degrees of severity (Fig.  4) . The hepatic sinusoids of LPS-treated rats contained many PMNs, plump Kupffer cells, and small amounts of an eosinophilic, proteinaceous material. There were multifocal, irregularly shaped areas of midzonal hepatocellular necrosis. These lesions were characterized by hypereosinophilic parenchymal cells with small, pyknotic nuclei or by swollen, pale parenchymal cells with indistinct to absent nuclei and indistinct cytoplasmic borders. The necrotic foci contained degenerate PMNs. There were also foci of single-cell necrosis scattered throughout the tissue. Aroclor 1248 administration increased the severity of the hepatic lesions, but the nature of the lesions did not change.
PMNs were observed infrequently throughout the liver tissue from animals exposed to saline, regardless of co-treatment with Aroclor 1248 (Fig. 5) . A marked Environmental Health Perspectives * Volume 104, Number 6, June 1996 accumulation of PMNs was observed at 6 hr in livers from animals exposed to LPS, and this was not affected by co-administration of Aroclor 1248.
Isolated hepatocytes, either in the presence or absence of PMNs, were exposed to various concentrations of Aroclor 1248 for 16 hr (Fig. 6) . Neither 1 pg/ml nor 10 pg/ml Aroclor 1248 was toxic to the hepatocytes. Addition of PMNs to the hepatocyte cultures did not produce cytotoxicity in the absence of Aroclor 1248. However, stimulation of the PMNs with either 1 pg/ml or 10 pg/ml Aroclor 1248 resulted in a significant release of ALT into the culture medium. In a similar experiment in which hepatocytes were incubated with cell-free conditioned medium from PMNs exposed to Aroclor 1248 or its vehicle, no significant differences were observed in these two groups (data not shown).
Discussion
Under normal circumstances, the liver is exposed to small amounts of gut-derived LPS originating from gram-negative bacteria residing in the gastrointestinal tract. However, during sepsis or numerous disease states exposure may increase, and LPS may initiate a systemic inflammatory response leading to significant morbidity and mortality. PMNs have been demonstrated to play a key role in the development of organ injury during sepsis (6) . In such situations, enhancement of PMN activation or responsiveness by xenobiotic agents could lead to increased tissue injury. The ability of PCBs to enhance organ injury during an inflammatory event was examined in a model of LPS-induced hepatic injury. In this model, PMNs rapidly accumulate in large numbers in the hepatic sinusoids after administration of LPS and are required for development of hepatic injury (8, 10) . At the dose used in this study, rats exposed to LPS alone and killed 6 or 9 hr later developed mild hepatic necrosis. Administration of Aroclor 1248 increased the severity of the hepatic injury as evidenced by elevated ALT and ICDH activities in plasma and increased severity of hepatic lesions determined histologically. The pathological changes observed are consistent with previous studies describing hepatic injury in rats treated with LPS (8, 41) . In addition, co-treatment with Aroclor 1248 produced lethality, whereas no mortality occurred in animals exposed to LPS alone. Exposure to Aroclor 1248 alone up to 100 mg/kg did not produce hepatotoxicity. Aroclor 1248 (jig/ml) Figure 6 . Aroclor 1248 stimulates PMN-mediated hepatocellular cytotoxicity in co-culture. Hepatocytes were cultured in the presence or absence of PMNs and exposed to either 0, 1, or 10 pg/ml Aroclor 1248. The activity of alanine aminotransferase (ALT) was determined in the cell-free medium and the cell lysates 16 hr later, and the percentage of total ALT released was calculated as described in Materials and Methods; N = 5. *Significantly different from respective value in the absence of PMNs (p < 0.05).
tion, PCBs initially distribute in high concentration in the liver, which is a target organ for toxicity (15, 16, 47 (11, 13) . Reactive oxygen species, such as O°, may also play a contributing role in PMN-mediated tissue injury (14) . Because Aroclor 1248 can elicit PMN O°-production and degranulation, both mechanisms may contribute to potentiating PMNmediated tissue injury. It is also possible that PCBs may adversely affect hepatic parenchymal cells in a manner resulting in greater susceptibility to injury upon exposure to PMN-derived cytotoxic mediators.
In summary, Aroclor 1248 increased the hepatic injury that follows LPS administration. Because PMNs play a critical role in liver injury from LPS, these findings are consistent with previous studies demonstrating that PCBs can activate PMNs in vitro and sensitize animals to LPS-induced lethality. PCBs may act in a fashion analogous to inflammatory stimuli by activating PMNs to become cytotoxic, resulting in enhancement of PMN-mediated tissue injury during an inflammatory event. Studies with individual PCB congeners suggest that ortho-substituted PCBs can activate PMNs in vitro, whereas coplanar PCBs are inactive (23) . Because Aroclor 1248 is a mixture of PCB congeners, the respective roles for both ortho-substituted and coplanar congeners in the mechanism for enhanced liver injury upon LPS exposure is uncertain at this time.
